Cypress Asset Management Inc Pfizer Inc Transaction History

Cypress Asset Management Inc

$357 Million
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 09, 2024	BUY	$32.09 - $37.51 $431,289 - $504,134	13,440 New	13,440 $445,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $467,862 - $541,305	-12,953 Reduced 33.43%	25,795 $946,000
Q1 2023 May 25, 2023	SELL	$39.39 - $51.28 $154,763 - $201,479	-3,929 Reduced 9.21%	38,748 $1.58 Million
Q4 2022 Feb 28, 2023	SELL	$41.75 - $54.5 $59,493 - $77,662	-1,425 Reduced 3.23%	42,677 $2.19 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $41,790 - $51,016	-955 Reduced 2.12%	44,102 $1.93 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $60,489 - $71,721	-1,300 Reduced 2.8%	45,057 $2.36 Million
Q1 2022 Jun 06, 2022	SELL	$45.75 - $56.69 $427,442 - $529,654	-9,343 Reduced 16.77%	46,357 $2.4 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $217,012 - $321,685	5,252 Added 10.41%	55,700 $3.29 Million
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $4,749 - $6,100	-121 Reduced 0.24%	50,448 $2.17 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $53,864 - $61,020	-1,500 Reduced 2.88%	50,569 $1.98 Million
Q1 2021 Apr 22, 2021	SELL	$33.49 - $37.77 $51,541 - $58,128	-1,539 Reduced 2.87%	52,069 $1.89 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $11,881 - $15,108	-355 Reduced 0.66%	53,608 $1.97 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $22,574 - $26,484	-711 Reduced 1.3%	53,963 $1.98 Million
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $12,650 - $15,346	420 Added 0.77%	54,674 $1.79 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $5,297 - $7,569	196 Added 0.36%	54,254 $1.77 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $61,955 - $70,311	-1,882 Reduced 3.36%	54,058 $2.12 Million
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $16,569 - $21,486	-510 Reduced 0.9%	55,940 $2.01 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $12,942 - $14,532	-350 Reduced 0.62%	56,450 $2.45 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $16,875 - $18,540	-450 Reduced 0.79%	56,800 $2.41 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $70,900 - $80,833	-1,843 Reduced 3.12%	57,250 $2.5 Million
Q3 2018 Oct 19, 2018	SELL	$34.47 - $41.81 $53,083 - $64,387	-1,540 Reduced 2.54%	59,093 $2.6 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $200,353 - $213,596	-6,075 Reduced 9.11%	60,633 $2.2 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $307,133 - $356,317	-9,625 Reduced 12.61%	66,708 $2.37 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $211,866 - $224,797	-6,370 Reduced 7.7%	76,333 $2.77 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $2.56 Million - $2.82 Million	82,703	82,703 $2.95 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Account